Objective To investigate the clinical features of patients with pure red cell aplasia( PRCA) associated with human parvovirus B19( HPV B19) infection after liver transplantation. Methods The clinical data of 420 patients who underwent liver transplantation in 302 Hospital of PLA from July 2007 to July 2016 and were followed up regularly were collected,and among these patients,five had a progressive reduction in hemoglobin( Hb) level within a short period of time. Bone marrow cytological examination showed erythropoiesis disorders and positive HPV B19 Ig M,and the patients were diagnosed with PRCA after the exclusion of other causes. The patients were given human gamma- globulin,glucocorticoids,and adjustment of immunosuppressants. The patients' clinical manifestations during treatment and the changes in reticulocyte count( RC),Hb,white blood cell count( WBC),platelet count( PLT),and myelogram findings determined by peripheral blood cell analysis were observed,as well as the changes in liver and renal function parameters. Results After the multimodality therapy using human gamma- globulin,glucocorticoids,and red blood cell infusion,the five patients had significant alleviation in the symptoms of weakness,short breath,and dizziness,and the peripheral blood cell analysis showed recovery of Hb and RC,suggesting that anemia was corrected. Conclusion As for patients with PRCA associated with HPV B19 infection,early diagnosis and treatment with human gamma-globulin and glucocorticoids can achieve a good therapeutic effect.
[1]PANICHI V,RICCHIUTI G,SCATENA A,et al.Pure red cell aplasia induced by epoetin zeta[J].Clin Kidney J,2016,9(4):599-602.
|
[2]BREDL S,PLENTZ A,WENZEL JJ,et al.False-negative serology in patients with acute parvovirus B19 infection[J].J Clin Virol,2011,51(2):115-120.
|
[3]KERR JR.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease[J].J Clin Pathol,2016,69(4):279-291.
|
[4]DAO AT,YAMAZAKI H,TAKAMATSU H,et al.Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia[J].Ann Hematol,2016,95(5):771-781.
|
[5]HIROKAWA M.Progress in the clinical management of pure red cell aplasia and future prospects[J].Rinsho Ketsueki,2016,57(2):110-116.
|
[6]LI DL,LIANG TB.Etiology and diagnosis and treatment of pure red cell aplasia after solid organ transplantation[J].Natl Med J China,2006,86(42):3020-3022.(in Chinese)李栋林,梁廷波.实体器官移植后纯红细胞再生障碍性贫血的病因与诊治[J].中华医学杂志,2006,86(42):3020-3022.
|
[7]STALEY EM,SCHWARTZ J,PHAM HP.An update on ABO incompatible hematopoietic progenitor cell transplantation[J].Transfus Apher Sci,2016,54(3):337-344.
|
[8]HEEGAARD ED,BROWN KE.Human parvovirus B19[J].Clin Microbiol Rev,2002,15(3):485-505.
|
[9]KERR JR.A review of blood diseases and cytopenias associated with human parvovirus B19 infection[J].Rev Med Virol,2015,25(4):224-240.
|
[10]ROGO LD,MOKHTARI-AZAD T,KABIR MH,et al.Human parvovirus B19:a review[J].Acta Virol,2014,58(3):199-213.
|
[11]CRABOL Y,TERRIER B,ROZENBERG F,et al.Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection:a retrospective study of 10 patients and review of the literature[J].Clin Infect Dis,2013,56(7):968-977.
|
[12]EID AJ,BROWN RA,PATEL R,et al.Parvovirus B19 infection after transplantation:a review of 98 cases[J].Clin Infect Dis,2006,43(1):40-48.
|
[13]VINCENS NC,CARMINATTI M,FRANCO MF,et al.Posttransplant chronic anemia:parvovirus B19[J].J Bras Nefrol,2012,34(3):303-308.
|